A detailed history of Beacon Financial Advisory LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Beacon Financial Advisory LLC holds 8,211 shares of ABBV stock, worth $1.6 Million. This represents 0.57% of its overall portfolio holdings.

Number of Shares
8,211
Previous 7,498 9.51%
Holding current value
$1.6 Million
Previous $1.37 Million 3.15%
% of portfolio
0.57%
Previous 0.71%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 26, 2024

BUY
$154.79 - $180.76 $110,365 - $128,881
713 Added 9.51%
8,211 $1.41 Million
Q1 2024

May 01, 2024

SELL
$159.82 - $182.1 $1,758 - $2,003
-11 Reduced 0.15%
7,498 $1.37 Million
Q4 2023

Jan 23, 2024

BUY
$137.6 - $154.97 $825 - $929
6 Added 0.08%
7,509 $1.16 Million
Q3 2023

Oct 25, 2023

BUY
$133.59 - $154.65 $33,397 - $38,662
250 Added 3.45%
7,503 $1.12 Million
Q2 2023

Jul 17, 2023

BUY
$132.51 - $164.9 $2,120 - $2,638
16 Added 0.22%
7,253 $977,000
Q1 2023

Apr 18, 2023

BUY
$144.61 - $166.54 $31,091 - $35,806
215 Added 3.06%
7,237 $1.15 Million
Q4 2022

Jan 20, 2023

SELL
$138.31 - $165.87 $5,809 - $6,966
-42 Reduced 0.59%
7,022 $0
Q3 2022

Oct 21, 2022

SELL
$134.21 - $153.93 $447,590 - $513,356
-3,335 Reduced 32.07%
7,064 $948,000
Q2 2022

Jul 25, 2022

BUY
$137.62 - $174.96 $48,579 - $61,760
353 Added 3.51%
10,399 $1.59 Million
Q1 2022

Apr 27, 2022

SELL
$131.98 - $163.75 $16,233 - $20,141
-123 Reduced 1.21%
10,046 $1.63 Million
Q4 2021

Jan 21, 2022

SELL
$107.43 - $135.93 $9,668 - $12,233
-90 Reduced 0.88%
10,169 $1.38 Million
Q3 2021

Nov 15, 2021

BUY
$106.4 - $120.78 $298,877 - $339,271
2,809 Added 37.7%
10,259 $1.11 Million
Q2 2021

Jul 14, 2021

BUY
$105.21 - $117.21 $12,414 - $13,830
118 Added 1.61%
7,450 $839,000
Q1 2021

Apr 20, 2021

SELL
$102.3 - $112.62 $285,621 - $314,435
-2,792 Reduced 27.58%
7,332 $794,000
Q4 2020

Jan 25, 2021

BUY
$80.49 - $108.67 $80,007 - $108,017
994 Added 10.89%
10,124 $1.08 Million
Q3 2020

Oct 08, 2020

SELL
$85.91 - $100.83 $236,596 - $277,685
-2,754 Reduced 23.17%
9,130 $799,000
Q2 2020

Jul 07, 2020

BUY
$73.37 - $98.18 $15,774 - $21,108
215 Added 1.84%
11,884 $1.17 Million
Q1 2020

Apr 15, 2020

SELL
$64.5 - $97.79 $288,057 - $436,730
-4,466 Reduced 27.68%
11,669 $889,000
Q4 2019

Jan 24, 2020

BUY
$72.13 - $90.25 $1.16 Million - $1.46 Million
16,135 New
16,135 $1.43 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $344B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Beacon Financial Advisory LLC Portfolio

Follow Beacon Financial Advisory LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Beacon Financial Advisory LLC, based on Form 13F filings with the SEC.

News

Stay updated on Beacon Financial Advisory LLC with notifications on news.